Form D Explorer

Form C-AR — Genomic Expression, Inc.

0001665160-24-001421 · filed 2024-10-18

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Genomic Expression, Inc.
CIK: 1611868
Entity: Corporation
Jurisdiction: DE
Address: 100 CUMMINGS CENTER, SUITE 451C,
BEVERLY, MA 01915
Phone: —

Most recent fiscal year financials

Total assets

$1,024,831

Cash

—

Short-term debt

$288,027

Long-term debt

$472,665

Revenues

$222,724

COGS

—

Taxes paid

—

Net income

$-274,187

View original on SEC EDGAR.